STOCK TITAN

Elite Health Systems launches up to $4M private placement

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

Elite Health Systems Inc. commenced a private placement of common stock with expected gross proceeds of a minimum of $500,000 and a maximum of $4,000,000, priced at $0.60 per share. The company anticipates an initial closing within a month of November 16, 2026, and expects multiple closings.

If the placement raises at least $3,000,000, the company will issue, at no additional cost, one share for every two shares purchased in its prior $0.95-per-share financing to each investor in that financing, whether or not they participate in this placement. The company presently intends to use substantially all net proceeds for continued development of its wholly owned subsidiary, Elite Health Plan, Inc., and operational activities supporting that work.

CMS had accepted 2,407 new member applications for the subsidiary’s Medicare Advantage plan during the current Annual Enrollment Period as of November 18, 2026. The subsidiary was formed in 2017 to establish a managed care organization and is currently enrolling members.

Filing Explained

At June 30, 2026, cash equaled 87.6 days of second-quarter operating cash use, a backward-looking liquidity measure.

The company reports that its common-stock placement has commenced; if shares are issued, they would increase the share count and reduce existing holders’ percentage ownership, absent offsetting changes.

At June 30, 2026, the company reported $1,302,000 in cash and equivalents; this equals 87.6 days of second-quarter operating cash use.

Sources and calculations
  • Available liquidity against the last reported quarterly operating outflow, in days at that rate $1,302,000 / ($1,353,000 / 91) = 87.6 days
Item 3.02 Unregistered Sales of Equity Securities Securities
The company sold equity securities in a private placement or other unregistered transaction.
Expected gross proceeds $500,000 minimum to $4,000,000 maximum Private placement of common stock
Price per share $0.60 Private placement
Threshold for additional shares At least $3,000,000 Placement proceeds condition for prior financing investors
Additional share ratio 1 share for every 2 shares purchased Applies to each investor in the prior financing if the placement raises at least $3,000,000
Prior financing price per share $0.95 Financing used to determine eligibility for additional shares
Accepted member applications 2,407 applications Elite Health’s Medicare Advantage plan during the current Annual Enrollment Period, as of November 18, 2026
Anticipated initial closing Within a month From commencement of the placement on November 16, 2026
private placement financial
"commencement of a private placement of shares of the Company’s common stock"
A private placement is a sale of securities directly to a selected group of investors, typically institutions or accredited investors, instead of through a public offering. It lets a company raise money faster and with fewer regulatory steps; for existing shareholders it matters because the newly issued shares, often sold at a discount, increase the share count and can dilute their ownership.
Rule 506(b) regulatory
"exemption from registration available under Section 4(a)(2) and/or Rule 506(b)"
Rule 506(b) is a U.S. securities exemption that lets companies sell shares or debt privately without full public registration, provided sales are primarily to accredited investors, up to 35 non‑accredited but financially knowledgeable buyers, and there is no public advertising or solicitation. It matters to investors because offerings under 506(b) usually include less public disclosure than registered securities—like buying from a private seller rather than a retail store—so buyers must do more of their own fact‑checking and rely on their financial sophistication.
accredited investors regulatory
"all participants in the Private Placement will be accredited investors"
Accredited investors are individuals or entities considered to have enough financial knowledge and resources to understand and handle more complex and risky investments. They are often allowed to participate in private investment opportunities that are not available to the general public, similar to how experienced players might access exclusive clubs or events. This status helps ensure that investors can manage potential risks and rewards appropriately.
Annual Enrollment Period medical
"currently enrolling members as part of the Annual Enrollment Period"
A yearly window when individuals covered by certain health insurance programs can enroll in, cancel, or switch plans and make coverage choices for the coming year. Think of it like a seasonal shopping period for health coverage: the choices people make during this brief time determine insurers’ customer counts and revenue for the next year, so shifts in enrollment can materially affect insurance companies’ financial results and investor expectations.
Medicare Advantage medical
"establishing a managed care organization that will operate as a Medicare Advantage plan"
Medicare Advantage is a type of health insurance plan offered by private companies that covers services traditionally provided by government-run Medicare. Think of it as a bundled package that combines hospital, doctor, and other medical care into one plan, often with added benefits. For investors, it matters because the popularity and profitability of these plans can influence healthcare companies and the broader health insurance industry.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much is EHSI seeking in its private placement?

EHSI expects gross proceeds of a minimum of $500,000 and a maximum of $4,000,000, at $0.60 per share.

What additional shares could prior EHSI investors receive?

If the placement raises at least $3,000,000, each prior financing investor will receive one additional share for every two shares purchased in that financing, at no additional cost. The prior financing was priced at $0.95 per share, and investors qualify whether or not they participate in the placement.

How many Medicare Advantage applications had CMS accepted for Elite Health?

CMS had accepted 2,407 new member applications during the current Annual Enrollment Period as of November 18, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0001089815 0001089815 2026-11-16 2026-11-16
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): November 16, 2026
 
Elite Health Systems Inc.
(Exact name of registrant as specified in its charter)
 
Delaware
000-26575
52-1842411
(State of other jurisdiction of 
incorporation or organization)
(Commission 
File Number)
(I.R.S. Employer 
Identification No.)
                                             
1131 W 6th Street 
Ontario, CA
91762
(Address of principal executive offices)
(Zip Code)
         
Registrant's telephone number, including area code:
(949) 249-1170
 
Not Applicable
(Former name, former address and former fiscal year, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act: N/A
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
 
 
Emerging growth company         ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.         ☐
 

Item 3.02 Unregistered Sales of Equity Securities
 
Commencement of a Private Placement of Common Stock
 
On November 16, 2026, the Board of Directors of Elite Health Systems Inc. (the “Company”) announced the commencement of a private placement of shares of the Company’s common stock for expected gross proceeds of a minimum of $500,000 and up to a maximum of $4,000,000 at a price per share of $0.60 (the “Private Placement”). If the Company raises at least $3,000,000 in this offering at $0.60 per share, the Company will issue, at no additional cost, to each investor in its prior $0.95 per share financing one additional share of common stock for every two shares of common stock that investor purchased in the prior financing, whether or not the investor participates in this offering.
 
For the sale of securities in connection with the Private Placement, no general solicitation was used, no commissions were paid, all participants in the Private Placement will be accredited investors, and the Company will rely on the exemption from registration available under Section 4(a)(2) and/or Rule 506(b) of Regulation D promulgated under the Securities Act of 1933, as amended (the “Securities Act”) with respect to transactions by an issuer not involving any public offering. The Company will file a Form D with the SEC within 15 days of the first date of sale. The Company anticipates that an initial closing of the Private Placement will be completed within a month from date of its commencement and expects to hold multiple closings in connection with the Private Placement.
 
The Company presently intends to apply substantially all the net proceeds from the Private Placement toward the continued development of the business of Elite Health Plan, Inc. a wholly-owned subsidiary of the Company (“Elite Health”) and operational activities to support these efforts. Elite Health is a company with a limited operating history. It was formed in 2017 with the purpose of establishing a managed care organization that will operate as a Medicare Advantage plan for seniors. Elite Health is currently enrolling members as part of the Annual Enrollment Period (“AEP”) and as of November 18, 2026, the Centers for Medicare & Medicaid Services (‘CMS’) had accepted 2,407 new member applications for Elite Health’s Medicare Advantage plan during the current AEP.
 
This current report on Form 8-K is issued in accordance with Rule 135c under the Securities Act, and is neither an offer to sell any securities, nor a solicitation of an offer to buy, nor shall there be any sale of any such securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
 
2

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
Date: November 20, 2026
 
 
 
 
Elite Health Systems Inc.
 
 
 
 
By:
/s/ Prasad Jeereddi
 
Name:
Prasad Jeereddi
 
Title:
Chairman and CEO
 
3

Filing Exhibits & Attachments

4 documents

Keep reading